Informativa su Privacy e Cookies
Questo sito utilizza cookie tecnici funzionali, cookie analitici di terze parti anonimizzati, e cookie di terze parti che potrebbero profilare: accedendo a qualunque elemento/area del sito al di fuori di questo banner, acconsenti a ricevere i cookie secondo le tue Preferenze. Puoi liberamente consentire, negare o impostare le tue preferenze sull\'utilizzo dei Cookies tramite i link di seguito. Se vuoi saperne di più puoi consultare la pagina Informazioni su Privacy e Cookies. Ti ricordo che i Cookies saranno registrati sul tuo browser solo a seguito del tuo consenso e secondo la modalità tecniche consentite dai produttori software, puoi liberamente cancellare i Cookies in qualsiasi momento tramite l\'apposita funzione del tuo browser.  Se non consenti l\'utilizzo di alcuni Cookies si potrebbero verificare malfunzionamenti delle pagine web oppure alcuni contenuti potrebbero non funzionare. [user_consent_state] [cookie_audit columns=\"cookie,description\" heading=\"The below list details the cookies used in our website.\"]
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

No cookies to display.

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

No cookies to display.

[Correspondence] Gonorrhoea and chlamydia screening for asymptomatic people with HIV and HIV PrEP users: open issues

Di |2024-08-14T00:30:01+02:00Agosto 14th, 2024|Categorie: Coronavirus Lancet|

We read with great interest the Article by Vanbaelen and colleagues1 and the Review by Williams and colleagues2 on the need for asymptomatic screening for Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men (MSM). This topic is...

[Correspondence] Gonorrhoea and chlamydia screening for asymptomatic people with HIV and HIV PrEP users: open issues

Di |2024-08-14T00:30:01+02:00Agosto 14th, 2024|Categorie: Coronavirus Lancet|

We read with great interest the Article by Vanbaelen and colleagues1 and the Review by Williams and colleagues2 on the need for asymptomatic screening for Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men (MSM). This topic is...

[Articles] Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007–22)

Di |2024-08-14T00:30:01+02:00Agosto 14th, 2024|Categorie: Coronavirus Lancet|

Significant reductions in methicillin resistance in S aureus, vancomycin-resistant E faecium, and fluoroquinolone resistance across multiple pathogens suggest that control efforts have had an effect on resistance. The rise in extended-spectrum β-lactam...

[Articles] Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007–22)

Di |2024-08-14T00:30:01+02:00Agosto 14th, 2024|Categorie: Coronavirus Lancet|

Significant reductions in methicillin resistance in S aureus, vancomycin-resistant E faecium, and fluoroquinolone resistance across multiple pathogens suggest that control efforts have had an effect on resistance. The rise in extended-spectrum β-lactam...

[Articles] Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study

Di |2024-08-13T00:30:02+02:00Agosto 13th, 2024|Categorie: Coronavirus Lancet|

After a single VLA1553 vaccination, chikungunya virus-neutralising antibodies above the threshold considered to be protective persisted up to 2 years and there were no long-term serious adverse events related to vaccination. VLA1553 is an efficient and...

[Articles] Effect of indoor residual spraying on sandfly abundance and incidence of visceral leishmaniasis in India, 2016–22: an interrupted time-series analysis and modelling study

Di |2024-08-10T00:30:01+02:00Agosto 10th, 2024|Categorie: Coronavirus Lancet|

Indoor residual spraying has substantially reduced sandfly abundance in India, which has contributed to reductions in visceral leishmaniasis and related deaths. To prevent the re-emergence of visceral leishmaniasis as a public health problem, surveilla...

[Articles] Effect of indoor residual spraying on sandfly abundance and incidence of visceral leishmaniasis in India, 2016–22: an interrupted time-series analysis and modelling study

Di |2024-08-10T00:30:01+02:00Agosto 10th, 2024|Categorie: Coronavirus Lancet|

Indoor residual spraying has substantially reduced sandfly abundance in India, which has contributed to reductions in visceral leishmaniasis and related deaths. To prevent the re-emergence of visceral leishmaniasis as a public health problem, surveilla...

[Articles] Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial

Di |2024-08-10T00:30:01+02:00Agosto 10th, 2024|Categorie: Coronavirus Lancet|

A regimen consisting of 2 days of intraurethral LBP-EC01 and 3 days of concurrent intravenous LBP-EC01 (1 × 1010 PFU) and oral TMP–SMX twice a day was well tolerated, with consistent pharmacokinetic profiles in urine and blood. LBP-EC01 and TMP–SMX dos...

[Articles] Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial

Di |2024-08-10T00:30:01+02:00Agosto 10th, 2024|Categorie: Coronavirus Lancet|

A regimen consisting of 2 days of intraurethral LBP-EC01 and 3 days of concurrent intravenous LBP-EC01 (1 × 1010 PFU) and oral TMP–SMX twice a day was well tolerated, with consistent pharmacokinetic profiles in urine and blood. LBP-EC01 and TMP–SMX dos...

[Personal View] The panzootic spread of highly pathogenic avian influenza H5N1 sublineage 2.3.4.4b: a critical appraisal of One Health preparedness and prevention

Di |2024-08-10T00:30:01+02:00Agosto 10th, 2024|Categorie: Coronavirus Lancet|

Changes in the epidemiology and ecology of H5N1 highly pathogenic avian influenza are devastating wild bird and poultry populations, farms and communities, and wild mammals worldwide. Having originated in farmed poultry, H5N1 viruses are now spread glo...

[Personal View] The panzootic spread of highly pathogenic avian influenza H5N1 sublineage 2.3.4.4b: a critical appraisal of One Health preparedness and prevention

Di |2024-08-10T00:30:01+02:00Agosto 10th, 2024|Categorie: Coronavirus Lancet|

Changes in the epidemiology and ecology of H5N1 highly pathogenic avian influenza are devastating wild bird and poultry populations, farms and communities, and wild mammals worldwide. Having originated in farmed poultry, H5N1 viruses are now spread glo...

Torna in cima